Filing Details
- Accession Number:
- 0001123292-16-003076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-19 16:27:24
- Reporting Period:
- 2016-12-16
- Filing Date:
- 2016-12-19
- Accepted Time:
- 2016-12-19 16:27:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1588972 | Recro Pharma Inc. | REPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553599 | Karen Flynn | C/O Recro Pharma, Inc. 490 Lapp Road Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-16 | 800 | $6.71 | 800 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
